Imaging transplanted stem cells in real time using an MRI dual-contrast method.

Area of Science:

• Biomedical Engineering
• Neuroscience
• Regenerative Medicine

Background:

• Stem cell therapies show promise for brain injury repair.
• Noninvasive monitoring of transplanted stem cells using MRI is crucial.
• Current methods struggle to detect stem cell death post-transplantation.

Purpose of the Study:

• To investigate a dual-contrast MRI technique for monitoring stem cell delivery, migration, and death.
• To assess the feasibility of distinguishing live from dead stem cells using MRI.
• To validate the technique for managing stem cell therapies.

Main Methods:

• Human mesenchymal stem cells were dual-labeled with SPIONs and GdDTPA.
• Cell viability, proliferation, and differentiation were evaluated.
• MRI phantoms and in vivo mouse models (immune-competent and immune-deficient) with brain injury were used.
• Bioluminescence imaging validated MRI results.

Main Results:

• Live cells exhibited negative T2/T2* MRI contrast for tracking.
• Cell death generated a positive T1 MRI contrast, indicating cell death.
• The technique successfully distinguished between live and dead cells in phantoms and in vivo.
• Validated results using bioluminescence imaging.

Conclusions:

• Dual-contrast MRI can effectively monitor stem cell delivery, migration, and death.
• This technique offers a promising tool for managing stem cell therapies.
• Improved monitoring of cell fate can enhance the efficacy and safety of regenerative medicine approaches.